Evidence map›Paper›PMID 30430184›Full record

ArticleExperimental brain research2019

Abnormal eyeblink conditioning is an early marker of cerebellar dysfunction in preclinical SCA3 mutation carriers.

J van Gaalen, R P P W M Maas, E F Ippel, M W Elting, K Y van Spaendonck-Zwarts, S Vermeer, C Verschuuren-Bemelmans, D Timmann, Bart P van de Warrenburg

Open access · hybridAbstract read
In one paragraph

Article in Experimental brain research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neurophysiology of cerebellar ataxias and gait disorders.Clinical neurophysiology practice · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Anatomical Variations of the Supraorbital and Supratrochlear Nerves: Their Intraorbital Course and Relation to the Supraorbital Margin.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

J van GaalenDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
R P P W M MaasDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
E F IppelDepartment of Medical Genetics, University Medical Center, Utrecht, The Netherlands.
M W EltingDepartment of Genetics, VU University Medical Center, Amsterdam, The Netherlands.
K Y van Spaendonck-ZwartsDepartment of Genetics, Academic Medical Center, Amsterdam, The Netherlands.
S VermeerFamily Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
C Verschuuren-BemelmansDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
D TimmannDepartment of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Bart P van de WarrenburgDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. bart.vandewarrenburg@radboudumc.nl.
Radboud University Medical Center · NLAcademic Medical Center · NLAmsterdam UMC Location VUmc · NLThe Netherlands Cancer Institute · NLUniversity Medical Center Utrecht · NLUniversity of Duisburg-Essen · DEUniversity of Groningen · NL

Funding

Jacques und Gloria Gossweiler-Stiftung x
6 · The paper itself

Abstract

backgroundSpinocerebellar ataxias (SCAs) are a group of autosomal dominantly inherited degenerative diseases. As the pathological process probably commences years before the first appearance of clinical symptoms, preclinical carriers of a SCA mutation offer the opportunity to study the earliest stages of cerebellar dysfunction and degeneration. Eyeblink classical conditioning (EBCC) is a motor learning paradigm, crucially dependent on the integrity of the olivocerebellar circuit, and has been shown to be able to detect subtle alterations of cerebellar function, which might already be present in preclinical carriers.

methodsIn order to acquire conditioned responses, we performed EBCC, delay paradigm, in 18 preclinical carriers of a SCA3 mutation and 16 healthy, age-matched controls by presenting repeated pairings of an auditory tone with a supraorbital nerve stimulus with a delay interval of 400 ms.

resultsPreclinical carriers acquired significantly less conditioned eyeblink responses than controls and learning rates were significantly reduced. This motor learning defect was, however, not associated with the predicted time to onset.

conclusionsEBCC is impaired in preclinical carriers of a SCA3 mutation, as a result of impaired motor learning capacities of the cerebellum and is thus suggestive of cerebellar dysfunction. EBCC can be used to detect but probably not monitor preclinical cerebellar dysfunction in genetic ataxias, such as SCA3.

Indexed as

Prodromal SymptomsAdultAtaxin-3BlinkingConditioning, EyelidElectromyographyFemaleHeterozygoteHumansMaleMiddle AgedRepressor ProteinsSpinocerebellar AtaxiasYoung AdultAtaxin-3ATXN3 protein, humanRepressor ProteinsCerebellar dysfunctionEyeblink conditioningPreclinical carriersSCA3

Identifiers

PMID30430184
PMCPMC6373441
OpenAlexW2901651344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.